Drug name - Brisdelle
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7598271 | SEBELA IRELAND LTD | Crystalline paroxetine methane sulfonate |
May, 2025
(2 years from now) | |
| US8946251 | SEBELA IRELAND LTD | Method of treating thermoregulatory dysfunction with paroxetine |
Aug, 2026
(3 years from now) | |
| US8658663 | SEBELA IRELAND LTD | Method of treating thermoregulatory disfunction with paroxetine |
Apr, 2029
(6 years from now) | |
| CN1092654C | SEBELA IRELAND LTD | 4-Phenyl-Piperidine Compound |
Aug, 2008
(14 years ago) | |
| CN1256692A | SEBELA IRELAND LTD | 4-Phenyl-Piperidine Compound |
Aug, 2008
(14 years ago) | |
| CN101505759A | SEBELA IRELAND LTD | Method Of Treating Thermoregulatory Dysfunction With Paroxetine |
Aug, 2013
(9 years ago) | |
| EP994872A1 | SEBELA IRELAND LTD | 4-Phenylpiperidine Compounds |
Jun, 2017
(5 years ago) | |
| EP994872B1 | SEBELA IRELAND LTD | 4-Phenylpiperidine Compounds |
Jun, 2017
(5 years ago) | |
| EP994872B9 | SEBELA IRELAND LTD | 4-Phenylpiperidine Compounds |
Jun, 2017
(5 years ago) | |
| EP2068881A2 | SEBELA IRELAND LTD | Method Of Treating Thermoregulatory Disfunction With Paroxetine |
Jul, 2027
(4 years from now) | |
| EP2068881B1 | SEBELA IRELAND LTD | Method Of Treating Thermoregulatory Disfunction With Paroxetine |
Jul, 2027
(4 years from now) | |
| EP2068881A4 | SEBELA IRELAND LTD | Method Of Treating Thermoregulatory Disfunction With Paroxetine |
Jul, 2027
(4 years from now) | |
| EP2719385B1 | SEBELA IRELAND LTD | Method Of Treating Thermoregulatory Disfunction With Paroxetine |
Jul, 2027
(4 years from now) | |
| EP2719385A1 | SEBELA IRELAND LTD | Method Of Treating Thermoregulatory Disfunction With Paroxetine |
Jul, 2027
(4 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9393237 | SEBELA IRELAND LTD | Method of treating thermoregulatory dysfunction with paroxetine |
Aug, 2026
(3 years from now) | |
Drugs and Companies using PAROXETINE MESYLATE ingredient
Treatment: Treatment of moderate to severe vasomotor symptoms associated with menopause
Dosage: CAPSULE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 7.5MG BASE | CAPSULE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.